The president of the “CureVac” company, Franz Werner Haas, said, Thursday, that the tests of the corona vaccine produced by the company on animals show that it is effective against different strains from the United Kingdom and South Africa.
“The results of the initial experiments regarding the effects of the vaccine on corona mutations will be published soon,” Haas added, in front of European Union lawmakers, indicating that his company expects the European Union to approve its vaccine by next June.
Source: Roxel – (Reuters)